Literature DB >> 12646761

Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis.

Mona Pache1, Hedwig J Kaiser, Nino Akhalbedashvili, Carmen Lienert, Barbara Dubler, Ludwig Kappos, Josef Flammer.   

Abstract

In order to evaluate whether plasma levels of the potent vasoconstrictor endothelin-1 (ET-1) are increased in patients with multiple sclerosis (MS) and whether these patients exhibit an ET-1-mediated vascular dysregulation, ET-1 plasma levels were measured in 30 patients with MS. Blood flow velocities in the ophthalmic artery, central retinal artery, central retinal vein, short lateral posterior ciliary artery, and short medial posterior ciliary artery were assessed in parallel. ET-1 plasma levels were significantly increased in MS patients when compared to sex- and age-matched healthy controls (2.0 +/- 0.4 pg/ml, range 1.1-2.8 vs. 1.5 +/- 0.2 pg/ml, range 0.9-2.0; p < 0.001). Moreover, the patients exhibited significant alterations of extraocular blood flow. The role of ET-1 in the inflammatory process remains to be clarified. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646761     DOI: 10.1159/000069085

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  35 in total

1.  Retinal Tissue Perfusion in Patients with Multiple Sclerosis.

Authors:  Yi Liu; Silvia Delgado; Hong Jiang; Ying Lin; Jeffrey Hernandez; Yuqing Deng; Giovana Rosa Gameiro; Jianhua Wang
Journal:  Curr Eye Res       Date:  2019-05-15       Impact factor: 2.424

2.  Color Doppler imaging in optic neuritis with multiple sclerosis.

Authors:  Cengiz Akarsu; Funda Uysal Tan; Tuba Kendi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-15       Impact factor: 3.117

3.  The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma.

Authors:  Noriko Himori; Hiroshi Kunikata; Yukihiro Shiga; Kazuko Omodaka; Kazuichi Maruyama; Hidetoshi Takahashi; Toru Nakazawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-30       Impact factor: 3.117

Review 4.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 5.  Optical Coherence Tomography of Choroid in Common Neurological Diseases.

Authors:  Federico DI Staso; Marco Ciancaglini; Solmaz Abdolrahimzadeh; Fabian D'Apolito; Gianluca Scuderi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

6.  [Primary open-angle glaucoma and systemic diseases].

Authors:  M Pache
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 7.  Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?

Authors:  Miguel D'haeseleer; Stéphanie Hostenbach; Ilse Peeters; Souraya El Sankari; Guy Nagels; Jacques De Keyser; Marie B D'hooghe
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

8.  Multiple sclerosis and optic nerve: an analysis of retinal nerve fiber layer thickness and color Doppler imaging parameters.

Authors:  H T Akçam; I Y Capraz; Z Aktas; H Z Batur Caglayan; S Ozhan Oktar; M Hasanreisoglu; C Irkec
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

9.  Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis.

Authors:  K Kircher; G Weigert; H Resch; G Garhöfer; G T Dorner; G Fuchsjäger Mayrl; A Reitner; L Schmetterer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-25       Impact factor: 3.117

10.  Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

Authors:  Miguel D'haeseleer; Roel Beelen; Yves Fierens; Melissa Cambron; Anne-Marie Vanbinst; Christian Verborgh; Johan Demey; Jacques De Keyser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.